Literature DB >> 16370142

Role of insulin-like growth factors in neuronal plasticity and neuroprotection.

Ignacio Torres Aleman1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16370142     DOI： 10.1007/0-387-26274-1_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  POTENTIAL NON-GROWTH USES OF rhIGF-I.

Authors:  Roy J Kim; Adda Grimberg
Journal:  Growth Genet Horm       Date:  2007-03

Review 2.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

3.  The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

4.  Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling.

Authors:  David Dávila; Ignacio Torres-Aleman
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

5.  Lack of nAChR activity depresses cochlear maturation and up-regulates GABA system components: temporal profiling of gene expression in alpha9 null mice.

Authors:  Sevin Turcan; Donna K Slonim; Douglas E Vetter
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

6.  Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity.

Authors:  David Dávila; Silvia Fernández; Ignacio Torres-Alemán
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

Review 7.  The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders.

Authors:  Filippo Caraci; Carla Busceti; Francesca Biagioni; Eleonora Aronica; Federica Mastroiacovo; Irene Cappuccio; Giuseppe Battaglia; Valeria Bruno; Andrea Caricasole; Agata Copani; Ferdinando Nicoletti
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 4.414

8.  Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations.

Authors:  David Olmos; Ana Sofia Martins; Robin L Jones; Salma Alam; Michelle Scurr; Ian R Judson
Journal:  Sarcoma       Date:  2011-05-03

9.  Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Oana Zanoaga; Valentina Pileczki; Claudia Gherman; Ioana Berindan-Neagoe; Radu Septimiu Campian
Journal:  Onco Targets Ther       Date:  2015-02-20       Impact factor: 4.147

10.  Multimodal MRI for early diabetic mild cognitive impairment: study protocol of a prospective diagnostic trial.

Authors:  Ying Yu; Qian Sun; Lin-Feng Yan; Yu-Chuan Hu; Hai-Yan Nan; Yang Yang; Zhi-Cheng Liu; Wen Wang; Guang-Bin Cui
Journal:  BMC Med Imaging       Date:  2016-08-24       Impact factor: 1.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.